被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Singapore: HSA updates on products found overseas that contain potent ingredients (Nov 2022) (English only) |
| |
The Health Sciences Authority (HSA) would like to update the public on products that have been found and reported by overseas regulators in Nov 2022 to contain potent ingredients which are not allowed in these products and may cause side effects. This information is provided to increase awareness on safety issues of such products found overseas, which may impact the local population.
There are 39 affected products listed in this announcement. For details of the affected products, please refer to the website in HSA.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/safety-alert/hsa-updates-on-products-found-overseas-that-contain-potent-ingredients-(november-2022)
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by the United States Food and Drug Administration, and was posted on the Drug Office website on 11 Nov 2022 and 22 Nov 2022.
Ends/Saturday, Dec 3, 2022
Issued at HKT 12:00
|
| |
